Rok Grahek,Andrija Lebar,Petra Draksler,Bostjan Petek,Jerneja Opara,Klemen Naversnik,Petra Bozic
申请号：
US15114890
公开号：
US20160346207A1
申请日:
2015.02.04
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention belongs to the field of pharmaceutical industry and relates to a solid pharmaceutical composition comprising androgen receptor antagonists, e.g. Enzalutamide or ARN-509, as well as to processes for preparing the same. The solid pharmaceutical compositions are useful in the treatment of prostate cancer.
